Research

Gipson-Reichardt Honored for Contributions to Drug Abuse Research

Cassandra Gipson-Reichardt, Ph.D. received the Joseph Cochin Young Investigator Award for Excellence in recognition of her contributions to drug abuse research.
Cassandra Gipson-Reichardt, Ph.D. received the Joseph Cochin Young Investigator Award for Excellence in recognition of her contributions to drug abuse research.

LEXINGTON, Ky. (May 26, 2021) — University of Kentucky College of Medicine researcher Cassandra Gipson-Reichardt, Ph.D., has received the College on Problems of Drug Dependence’s (CPDD) 2021 Joseph Cochin Young Investigator Award for Excellence.

The annual award recognizes an investigator under 40 years old who has demonstrated excellence in their field of research and authored several publications. It is one of the most prestigious honors awarded by the CPDD, the longest standing group in the U.S. dedicated to addressing issues of drug dependence and abuse.

“I am so grateful to receive the Cochin award this year,” said Gipson-Reichardt, an associate professor in the Department of Family and Community Medicine. “This award is meaningful to me because my colleagues, mentors, family and friends have contributed so much to my career. To be recognized in this way truly is wonderful and it is a reflection of the support I have received.”

Gipson-Reichardt is a preclinical addiction neuroscientist, focusing on glutamatergic, cholinergic, ovarian hormone and neuroimmune mechanisms involved in nicotine and opioid/stimulant polysubstance use. Her research has revealed new neurobiological mechanisms of addiction and has the potential to contribute to the development of treatments to improve drug use cessation outcomes.

"The Joseph Cochin Award is the highest honor CPDD bestows on an early career researcher,” said William Stoops, Ph.D., professor in UK’s College of Medicine and CPDD president-elect. “Dr. Gipson-Reichardt's receipt of the award this year highlights her numerous important research contributions to our understanding of the basic neuroscience underlying substance use disorders."

Gipson-Reichardt will be honored at the CPDD 83rd Annual Scientific Virtual Meeting June 21-24. For more information visit https://cpdd.org/meetings/current-meeting/ or https://cpdd.org/gipson-reichardt-named-cochin-award-winner/.

 

As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.   

In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and named a “Diversity Champion” by INSIGHT into Diversity, a testament to our commitment to advance Kentucky and create a community of belonging for everyone. While our mission looks different in many ways than it did in 1865, the vision of service to our Commonwealth and the world remains the same. We are the University for Kentucky.